The Effect of Initial Versus Sequential Chemoradiotherapy on Survival in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma - Top-Institutions - MDSpire

The Effect of Initial Versus Sequential Chemoradiotherapy on Survival in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma

  • By

  • Xuechun Luo

  • Fan Peng

  • Xi Lin

  • Yun Li

  • Zhenyu Ding

  • April 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Thoracic Oncology
    • Radiation Oncology
    • Medical Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Thoracic Surgery
    • Medical Oncology
    • Radiation Oncology

  • #3

    Fudan University Shanghai Cancer Center
    Fudan University Shanghai Cancer Center

    Shanghai, China

    Key Differentiators

    • Medical Oncology
    • Radiation Oncology
    • Esophageal Cancer Research

  • #4

    The University of Texas Southwestern Medical Center
    The University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Radiation Oncology
    • Medical Oncology
    • Thoracic Oncology

  • #5

    National Cancer Center Hospital
    National Cancer Center Hospital

    Tokyo, Japan

    Key Differentiators

    • Medical Oncology
    • Radiation Oncology
    • Surgical Oncology

Original Source(s)

The Effect of Initial Versus Sequential Chemoradiotherapy on Survival in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma

  • by Xuechun Luo, Fan Peng, Xi Lin, Yun Li, Zhenyu Ding

  • April 29, 2026

Related Content

Methylation-regulated miR-374a-5p and miR-374b-5p Suppress Glycolysis and Malignant Progression of Head and Neck Squamous Cell Carcinoma by Targeting DEPDC1

Severe IL-6–dominant immune-mediated inflammatory response complicated by probable arginine vasopressin deficiency following ivonescimab-based therapy in advanced EGFR-mutant lung squamous cell carcinoma: a case report

The microbiome-inflammation-immune axis in oral squamous cell carcinoma: from mechanistic insights to therapeutic perspectives